Hospitalization

As an early-stage treatment, Paxlovid may prevent COVID-19-related hospitalization among patients with mild-to-moderate COVID-19 cases, investigators say.

A fourth dose of Pfizer’s COVID-19 vaccine cuts the risk of infection and severe illness in older adults when compared to a third dose given months earlier, a new study from Israel finds.

Mortality rates for Medicare beneficiaries with non-COVID-19-related illness increased both in the hospital and at 30 days post-discharge during the pandemic, a large new study has found.

Older adults experiencing severe financial strain have a 61% higher risk of dying within six months of hospital discharge than their peers who report no problems meeting monthly expenses, investigators...

The results suggest that remdesivir (brand name Veklury) could be used to treat outpatients early in the disease course, researchers say. The drug currently is authorized for use only in hospitalized COVID-19...

The results of a national study suggest that memory care may be best equipped to handle the needs of residents with dementia when compared to the general assisted living setting.

The next hospital crisis may be dementia behavioral emergencies, psychiatrist says … Neurologists prescribing Alzheimer’s drug Aduhelm talk about practices and payments … Patients with diabetes may...

Outpatient treatment with the commonly available drug fluvoxamine (Luvox) compares favorably with more expensive treatments such as monoclonal antibodies, investigators say.

Patients who take anticoagulants before contracting COVID-19 are 43% less likely to be admitted to the hospital, and those who are given the drugs while hospitalized are less likely to die, according to...

Despite the known effectiveness of U.S.-sanctioned COVID-19 vaccines, some fully vaccinated individuals will still become infected. But their unvaccinated peers have five times the risk of infection and...